AI assistant
Supriya Lifescience Limited — Call Transcript 2022
Nov 3, 2022
59375_rns_2022-11-03_d9fa3444-b232-462b-b1b8-be6df54107bc.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [426 x 69] intentionally omitted <==
Date: November 3, 2022
To,
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 543434
National Stock Exchange of India Limited Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 NSE Symbol: SUPRIYA
Dear Sir/Madam,
Subject: Intimation of Earnings Call for quarter and half year ended September 30, 2022
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Friday, November 11, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2022. The invite giving requisite details including the pre-registration link and dial-in details is attached herewith.
This intimation is also being made available on the website of the Company at: https://supriyalifescience.com/investor-relation/
Kindly take the information on record.
Thanking you,
For Supriya Lifescience Limited
SHWETA Digitally signed by SHWETA SHIVDHARI SHIVDHARI SINGH Date: 2022.11.03 SINGH 11:35:49 +05'30' Shweta Singh Company Secretary & Compliance Officer Membership No.: A44973
Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: [email protected]
GOVT. RECOGNISED EXPORT HOUSE
Supriya Lifescience Ltd
Cordially Invites you to Earning call To discuss operational and financial performance for Q2 & H1 FY23
Friday, 11[th] November 2022 at 4:00 PM, IST Pre - Registration Link - Click Here
Participants
Dr. Satish Wagh - Chairman & Managing Director Dr. Saloni Wagh - Whole Time Director Mr. Rajeev Kumar Jain - Chief Executive Officer Mr. Ashish Nayak - Chief Financial Officer
Access Numbers +91 22 6280 1550 Primary Number +91 22 7115 8378 Hongkong: 800 964 448 Singapore: 800 101 2045 International Toll Free Number USA: 1 866 746 2133 UK: 0 808 101 1573
Dr. Shireesh Ambhaikar - Technical Lead
RSVP : Ms. Rasika Sawant, Orient Capital - IR
Contact / Email : +91 95944 57518/ [email protected]